Cystic fibrosis: The miracle drugs priced out of reach
Regulators around the world have questioned the high price set by Vertex Pharmaceuticals.
Similar Posts
Hospitals face rising cases of respiratory illnesses
Hospitals face rising cases of respiratory illnesses – CBS News Watch CBS News Hospitals across the country are dealing with higher cases of COVID-19, the flu and RSV. The increase is being fueled in part by holiday travel and gatherings. Meg Oliver has the latest. Be the first to know Get browser notifications for breaking…
At-home health test maker Thorne explores sale | Reuters News Agency
Business & FinanceDealsHealth 21 July 2023, 6:41 pm 1 minute Reuters exclusively reported that Thorne HealthTech Inc (THRN.O), a provider of at-home health tests and nutritional supplements, is exploring a sale. Market Impact Thorne’s shares ended trading on Friday up 12.9% at $5.95 on the news, giving the company a market value of $320 million….
What It’s Really Like To Get Fillers And Implants Removed, According To Plastic Surgeons
With all the changes in cosmetic surgery trends — from lip injections to implants and filler removal — we asked plastic surgeons about the process of dissolving fillers and whether there are any risks associated with the reversals that are making headlines. This is what experts recommend that people know before getting procedures so that…
Integrating Fitness into a Busy Schedule: Exercise Routines for the Active Professional
In today’s fast-paced world, balancing work, personal life, and fitness can be a daunting challenge. Busy professionals often find it difficult to carve out time for exercise amidst their hectic schedules. However, integrating fitness into a busy routine is not only possible but also essential for maintaining overall health and productivity. Here are practical tips…
Narcan, The Lifesaving Drug That Can Reverse An Opioid Overdose, Can Be Bought Over The Counter Soon
The Food and Drug Administration has approved Narcan, a naloxone nasal spray that can reverse opioid overdoses and save lives, for over-the-counter use. In an announcement Wednesday, FDA Commissioner Robert M. Califf said the move is meant to address a “dire public health need” and will help increase access and reduce opioid overdose deaths in…
Prescriptions for Eli Lilly’s new weight-loss drug get off to a strong start and confirm bright outlook
The launch of Eli Lilly ‘s weight-loss drug Zepbound — a key pillar of our investment thesis in the pharmaceuticals giant — is going swimmingly in the U.S., Jefferies said Friday. Weekly Zepbound prescriptions totaled 7,700 in the week ended Dec. 8, its fourth on the U.S. market, according to Jefferies, which cited data compiled…
